WASHINGTON (AP) — Scientists are testing an entirely new way to fight heart disease: a gene-editing treatment that might offer a one-time fix for high cholesterol. It’s very early stage research, ...
CRISPR-Cas systems are prokaryotic immune systems that confer resistance to foreign genetic elements such as plasmids and phages. CRISPR-Cas systems have been exploited for targeted genome editing. An ...
From cancer to Alzheimer’s: could a renewed focus on energy transform biomedicine? Including energy dynamics in research could improve our understanding of diseases and of the healing processes that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results